Elsevier Inc.

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Harnicar
    Harnicar
  3. Bhatt
    Bhatt
  4. Carlow
    Carlow
  5. Chung
    Chung
  6. Dahi
    Dahi
  7. Devlin
    Devlin
  8. Koehne
    Koehne
  9. Landau
    Landau
  10. Lin
    Lin

Groups

  1. Bone Marrow Transplant (4)
  2. Center for Hematologic Malignancies (4)
  3. Clinical Pharmacy Specialists (4)
  4. Department of Medicine (4)
  5. Hematologic Malignancies, Division of (4)
  6. Survivorship Research (4)
  7. Advanced Practice Providers (2)
  8. Biostatistics Service (2)
  9. CTCR Scholars (2)
  10. Epidemiology and Biostatistics (2)
Search Within
  1. "Bone Marrow Transplant"
  2. "Survivorship Research"
  3. "Stephen Harnicar"
Formats
  1. Meeting Abstract (4)
Groups
  1. Bone Marrow Transplant (4)
  2. Center for Hematologic Malignancies (4)
  3. Clinical Pharmacy Specialists (4)
  4. Department of Medicine (4)
  5. Hematologic Malignancies, Division of (4)
  6. Survivorship Research (4)

More Groups

People
  1. Sergio Giralt (4)
  2. Stephen Harnicar (4)
  3. Andrew Lin (2)
  4. Caitlin Sarubbi (2)
  5. David Chung (2)
  6. Dean Carlow (2)

More People

Years
  1. 2018 (2)
  2. 2014 (1)
  3. 2011 (1)
Publications
  1. Biology of Blood and Marrow Transplantation (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Feasibility and toxicity of Pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S.; Hoover, E.; Chung, D. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with hematopoietic stem cell transplant (HCT) for multiple myeloma (MM), AL amyloidosis (AL), lymphoma, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS)
    Meeting Abstract

    Shah, G. L.; Landau, H.; Sarubbi, C.; Schofield, R.; Lin, A.; Bhatt, V.; Harnicar, S.; Devlin, S. M.; Castro-Malaspina, H.; Chung, D. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Safety and efficiency of administering foscarnet in an intensive adult bone marrow transplant clinic: A multidisciplinary approach
    Meeting Abstract

    Kenny, S.; Jackson, L.; Coffey, G.; Eaton, A. A.; Giralt, S.; Barker, J. N.; Harnicar, S.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Management strategies for allogeneic hematopoetic stem cell transplant (HSCT) graft verus host disease (GVHD) prophylaxis in the setting of calcineurin inhibitor (CNI) toxicity
    Meeting Abstract

    Harnicar, S.; Mathew, S.; Adel, N.; Giralt, S.; Jakubowski, A.
    Biology of Blood and Marrow Transplantation (2011)

    Fulltext@MSK | Save